Research & Education
CURE Expert Connections
Email Sign Up
To start your customized experience click the start button
Customize your homepage by selecting specific cancer types.
Cancer of Unknown Primary
Diet and Exercise
Gastrointestinal stromal tumor
General Financial Topics
General Psychosocial Aspect Topics
Head & Neck Cancer
Mantle Cell Lymphoma
Metastatic Breast Cancer
Side Effect Management
Small Lymphocytic Lymphoma (SLL)
Advocacy & Research
Share Your Story
Newsletter Sign Up
Ovarian Cancer Heroes
Bone Health Champions
Terms & Conditions
Cure Media Group, LLC.
2 Clarke Drive
Cranbury, NJ 08512
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Patients with Mesothelioma See No Survival Benefit With Defactinib Maintenance Therapy
Maintenance therapy with defactinib failed to improve survival following front-line chemotherapy in patients with merlin-low malignant pleural mesothelioma, according to results from the phase 2 COMMAND trial.
Novel 'Theranostic' Screening Tool Shows Promise in Determining Kidney Cancer Treatment
Kristie L. Kahl
A novel imaging test developed at UT Southwestern may help to determine which patients with kidney cancer would benefit from treatment with immunotherapy.
Immunotherapy Side Effects Could Mean Treatment Is Working in Non-Small Cell Lung Cancer
Autoimmune skin toxicities in patients with non-small cell lung cancer mean patients may responds better to immune checkpoint inhibitors.
The Deep Breaths Within Resiliency
Getting back up matters when cancer knocks you down, but so does pausing for reflection.
Stepping on LEGO Blocks and Cancer False Alarms
As a cancer survivor, I am always on my toes.
Bad News Over the Phone, a Current Trend that Needs to Change
Should patients be given a choice on how they wish to receive bad news? One survivor seems to think so.
Living Beyond Small Cell Lung Cancer
After elucidating their current status, Nancy and Dan MacMillan provide parting advice to patients and caregivers who encounter a diagnosis of small cell lung cancer.
Small Cell Lung Cancer: Finding Support & Information
Thinking of their journey through small cell lung cancer, Nancy and Dan MacMillan shed light on the support and information they found useful.
Diagnosis and Treatment of Small Cell Lung Cancer
Nancy and Dan MacMillan reflect on Nancy’s diagnosis of small cell lung cancer and the treatment she received thereafter.
Conversations on Patient Priorities and Preferences Should Take Place Before Treatment
With so many cancer treatment options now available, clinicians may still fall short in understanding what’s important to patients.
Imbruvica Shows Promise as Maintenance Therapy for Patients With MCL
Dr. Reem Karmali
Maintenance therapy with Imbruvica appeared to be a feasible option for patients with mantle cell lymphoma, according to Dr. Reem Karmali.
'Out of the Blue' Diagnosis Linked to a Family History of Cancer Now Empowers Others
Sue Friedman, DVM
Sue Friedman, founder and executive director of FORCE, discussed how a breast cancer diagnosis at age 33 and a family history of cancer led to the creation of Facing Our Risk of Cancer Empowered.
Finding Hope in Darkness
In this week’s episode of the “
Talks Cancer” podcast, we spoke with a caregiver who found hope in the darkness after losing her son to lung cancer at just 29 years old.
What You Need to Know About Genomics
Kristie L. Kahl
In this week’s episode, we spoke with a patient and his doctor about genomic testing and how it can change treatment outcomes for patients with cancer.
The Basics of Bladder Cancer
Kristie L. Kahl
In this episode of “
Talks Cancer,” we spoke with a patient, an advocate and a doctor to learn more about bladder cancer and what others should know about the disease.
Not a member?
Sign up now!
Continue without login
OPTIONAL INFORMATION: The following information helps us tailor CURE to fit your needs
Please type below what best describes your interests and click on the selection(s):
I am a:
Please list other: